GSK (GSK)
35.30
0.00 (0.00%)
Upcoming Events
Latest Headlines
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
January 24, 2023 6:01 AM - StreetInsider
Form 6-K GSK PLC For: Jan 18
January 18, 2023 12:36 PM - SEC Filing
Citi Reiterates Neutral Rating on GlaxoSmithKline (GSK:LN) (GSK)
January 18, 2023 4:58 AM - StreetInsider
Form 6-K GSK PLC For: Jan 17
January 17, 2023 10:53 AM - SEC Filing
Form 6-K GSK PLC For: Jan 17
January 17, 2023 9:30 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP15.20 at Morgan Stanley
January 16, 2023 3:41 AM - StreetInsider
Form 6-K GSK PLC For: Jan 13
January 13, 2023 12:09 PM - SEC Filing
Form 6-K GSK PLC For: Jan 12
January 12, 2023 11:46 AM - SEC Filing
Morgan Stanley Calls Moderna (MRNA) a Catalyst Driven Idea
January 5, 2023 4:09 PM - StreetInsider
WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers
January 4, 2023 7:30 PM - PR NewsWire
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP16.50 at Stifel
January 4, 2023 3:18 AM - StreetInsider
Form 6-K GSK PLC For: Jan 03
January 3, 2023 12:09 PM - SEC Filing
JPMorgan Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Underweight
January 3, 2023 1:00 AM - StreetInsider
Form 6-K GSK PLC For: Dec 22
December 22, 2022 11:11 AM - SEC Filing
Form 6-K GSK PLC For: Dec 21
December 21, 2022 11:03 AM - SEC Filing
Form 6-K GSK PLC For: Dec 21
December 21, 2022 10:53 AM - SEC Filing
Form 6-K GSK PLC For: Dec 15
December 15, 2022 10:52 AM - SEC Filing
Form 6-K GSK PLC For: Dec 13
December 13, 2022 1:19 PM - SEC Filing
Wave Life Sciences (WVE) and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets
December 13, 2022 7:31 AM - StreetInsider
Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets
December 13, 2022 7:30 AM - Globe NewsWire
New data at ASH underscore the potential for durable, clinically important responses with momelotinib for myelofibrosis patients
December 11, 2022 5:33 PM - BizWire
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP17 at Citi
December 8, 2022 5:02 AM - StreetInsider
BofA Securities Reiterates Underperform Rating on GlaxoSmithKline (GSK:LN) (GSK)
December 8, 2022 3:12 AM - StreetInsider
Form 6-K GSK PLC For: Dec 07
December 7, 2022 6:29 AM - SEC Filing
UBS Reiterates Sell Rating on GlaxoSmithKline (GSK:LN) (GSK)
December 7, 2022 4:24 AM - StreetInsider
European stocks mixed; recession concerns clash with China reopening
December 7, 2022 4:12 AM - StreetInsider
GSK, Pfizer, Sanofi fend off thousands of U.S. lawsuits over alleged Zantac cancer link
December 6, 2022 2:59 PM - StreetInsider
GSK (GSK), Sanofi (SNY) Jump After US Court Win In Zantac Litigation - Bloomberg
December 6, 2022 2:24 PM - StreetInsider
GSK (GSK) Sees Mid-Day Gains
December 6, 2022 2:01 PM - StreetInsider
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
December 6, 2022 1:26 AM - StreetInsider
Form 6-K GSK PLC For: Dec 05
December 5, 2022 12:05 PM - SEC Filing
BofA Securities Moves GlaxoSmithKline (GSK:LN) (GSK) at Underperform
December 5, 2022 5:47 AM - StreetInsider
BofA Securities Moves GlaxoSmithKline (GSK) at Underperform
December 5, 2022 5:47 AM - StreetInsider
Form 6-K GSK PLC For: Dec 02
December 2, 2022 11:40 AM - SEC Filing
Form 6-K GSK PLC For: Dec 02
December 2, 2022 6:55 AM - SEC Filing
Form 6-K GSK PLC For: Dec 02
December 2, 2022 6:43 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP15.50 at Citi
December 2, 2022 4:08 AM - StreetInsider
Form 6-K GSK PLC For: Dec 01
December 1, 2022 12:20 PM - SEC Filing
Major Corporations Launch New Coalition to Help End HIV in the United States
December 1, 2022 8:00 AM - BizWire
ViiV Healthcare Unveils a New Global Study Revealing Three Quarters of People Believe There Are Still Negative Perceptions When It Comes to People Living With HIV
November 30, 2022 7:01 PM - BizWire
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP15.35 at Morgan Stanley
November 30, 2022 4:22 AM - StreetInsider
Form 6-K GSK PLC For: Nov 25
November 25, 2022 6:36 AM - SEC Filing
Form 6-K GSK PLC For: Nov 22
November 22, 2022 6:24 AM - SEC Filing
Form 6-K GSK PLC For: Nov 21
November 21, 2022 11:55 AM - SEC Filing
Form 6-K GSK PLC For: Nov 15
November 15, 2022 6:39 AM - SEC Filing
GlaxoSmithKline (GSK:LN) (GSK) PT Raised to GBP16.30 at Stifel
November 15, 2022 4:23 AM - StreetInsider
Form 6-K GSK PLC For: Nov 14
November 14, 2022 6:27 AM - SEC Filing
UBS Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Sell
November 14, 2022 5:23 AM - StreetInsider
'Uncertain times ahead': GlaxoSmithKline (GSK) stock falls 4% as UBS moves to Sell
November 11, 2022 9:26 AM - StreetInsider
UBS Downgrades GlaxoSmithKline (GSK) to Sell
November 11, 2022 8:54 AM - StreetInsider
UPDATE: UBS Downgrades GlaxoSmithKline (GSK:LN) (GSK) to Sell
November 11, 2022 5:27 AM - StreetInsider
Form 6-K GSK PLC For: Nov 10
November 10, 2022 1:48 PM - SEC Filing
Form 6-K GSK PLC For: Nov 10
November 10, 2022 11:06 AM - SEC Filing
Form 6-K GSK PLC For: Nov 10
November 10, 2022 6:24 AM - SEC Filing
European stocks edge lower; earnings season in full flow
November 10, 2022 5:23 AM - StreetInsider
Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBr
November 8, 2022 8:05 AM - Globe NewsWire
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP16 at JPMorgan
November 8, 2022 3:13 AM - StreetInsider
Form 6-K GSK PLC For: Nov 07
November 7, 2022 6:04 AM - SEC Filing
Form 6-K GSK PLC For: Nov 03
November 3, 2022 6:56 AM - SEC Filing
Form 6-K GSK PLC For: Nov 02
November 2, 2022 12:14 PM - SEC Filing
GlaxoSmithKline (GSK) Posts Q3 Results, Lifts Outlook
November 2, 2022 8:42 AM - StreetInsider
GSK (GSK) Announces FDA Priority Review for BLA for Adult RSV Vaccine
November 2, 2022 8:37 AM - StreetInsider
CVS Health, AMD, Yum Brands Rise Premarket; Estée Lauder, Airbnb Fall
November 2, 2022 8:16 AM - StreetInsider
Form 6-K GSK PLC For: Nov 02
November 2, 2022 7:08 AM - SEC Filing
European Stocks Edge Higher; GSK Shines Ahead of Fed Rate Decision
November 2, 2022 5:50 AM - StreetInsider
Form 6-K GSK PLC For: Nov 01
November 1, 2022 12:01 PM - SEC Filing
Full Article List
